<?xml version='1.0' encoding='UTF-8'?>
<article doi="10.15252/msb.20209628"><fig id="34260"><title>: The landscape of ACE2 expression levels alterations in response to drug treatments across cell lines in CMAP (Subramanian et al, 2017).</title><label>Figure 1</label><graphic href="https://api.sourcedata.io/file.php?figure_id=34260"/><sd-panel panel_id="89571">Differential <sd-tag id="sdTag13" source="sdapi" category="assay" entity_type="None" role="None" text="expression" ext_ids="BAO_0002785" ext_dbs="" in_caption="True" ext_names="gene expression assay" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">expression</sd-tag> analysis for <sd-tag id="sdTag14" source="sdapi" category="None" entity_type="gene" role="assayed" text="ACE2" ext_ids="59272" ext_dbs="" in_caption="True" ext_names="ACE2" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/"><em>ACE2</em></sd-tag> <sd-tag id="sdTag15" source="sdapi" category="assay" entity_type="None" role="None" text="expression" ext_ids="BAO_0002785" ext_dbs="" in_caption="True" ext_names="gene expression assay" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">expression</sd-tag> changes in treated vs control samples was performed with the level 3 CMAP data of 24 hours response values using limma (Ritchie et al, 2015; Methods). Volcano plots showing the log fold-change (X-axis) and uncorrected negative log<sub>10</sub>P value (Y-axis) of <sd-tag id="sdTag16" source="sdapi" category="None" entity_type="gene" role="assayed" text="ACE2" ext_ids="59272" ext_dbs="" in_caption="True" ext_names="ACE2" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/"><em>ACE2</em></sd-tag> <sd-tag id="sdTag17" source="sdapi" category="assay" entity_type="None" role="None" text="expression" ext_ids="BAO_0002785" ext_dbs="" in_caption="True" ext_names="gene expression assay" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">expression</sd-tag> changes are given for <strong>(A)</strong> 48 antihypertensive drugs The enrichment of positive/negative <sd-tag id="sdTag18" source="sdapi" category="None" entity_type="gene" role="assayed" text="ACE2" ext_ids="59272" ext_dbs="" in_caption="True" ext_names="ACE2" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/"><em>ACE2</em></sd-tag> <sd-tag id="sdTag19" source="sdapi" category="assay" entity_type="None" role="None" text="expression" ext_ids="BAO_0002785" ext_dbs="" in_caption="True" ext_names="gene expression assay" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">expression</sd-tag> regulators in different drug classes based on their mechanism of action (MOA) was tested with the <sd-tag id="sdTag20" source="sdapi" category="assay" entity_type="None" role="None" text="GSEA" ext_ids="BAO_0002356" ext_dbs="" in_caption="True" ext_names="GSEA-P enrichment analysis" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">GSEA</sd-tag> method as implemented in the R package fgsea (Segushichev, 2016; Methods), and the enrichment significance (negative log10 P values) is shown in bar plots in <strong>(B)</strong> , for the analysis on the 48 antihypertensive drugs <sd-tag id="sdTag21" source="sdapi" category="None" entity_type="molecule" role="intervention" text="CCBs" ext_ids="CHEBI:38215" ext_dbs="" in_caption="True" ext_names="calcium channel blocker" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=">CCBs</sd-tag>, <sd-tag id="sdTag22" source="sdapi" category="None" entity_type="molecule" role="intervention" text="calcium channel blockers" ext_ids="CHEBI:38215" ext_dbs="" in_caption="True" ext_names="calcium channel blocker" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=">calcium channel blockers</sd-tag>; <sd-tag id="sdTag23" source="sdapi" category="None" entity_type="molecule" role="intervention" text="ARBs" ext_ids="CHEBI:61016" ext_dbs="" in_caption="True" ext_names="angiotensin receptor antagonist" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=">ARBs</sd-tag>, <sd-tag id="sdTag24" source="sdapi" category="None" entity_type="molecule" role="intervention" text="angiotensin II type-I receptor blockers" ext_ids="CHEBI:61016" ext_dbs="" in_caption="True" ext_names="angiotensin receptor antagonist" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=">angiotensin II type-I receptor blockers</sd-tag>; <sd-tag id="sdTag25" source="sdapi" category="None" entity_type="molecule" role="intervention" text="ACEIs" ext_ids="CHEBI:35457" ext_dbs="" in_caption="True" ext_names="EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=">ACEIs</sd-tag>, <sd-tag id="sdTag26" source="sdapi" category="None" entity_type="molecule" role="intervention" text="angiotensin-converting enzyme inhibitors" ext_ids="CHEBI:35457" ext_dbs="" in_caption="True" ext_names="EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=">angiotensin-converting enzyme inhibitors</sd-tag> <graphic href="https://api.sourcedata.io/file.php?panel_id=89571"/></sd-panel><sd-panel panel_id="89573">Differential <sd-tag id="sdTag30" source="sdapi" category="assay" entity_type="None" role="None" text="expression" ext_ids="BAO_0002785" ext_dbs="" in_caption="True" ext_names="gene expression assay" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">expression</sd-tag> analysis for <sd-tag id="sdTag31" source="sdapi" category="None" entity_type="gene" role="assayed" text="ACE2" ext_ids="59272" ext_dbs="" in_caption="True" ext_names="ACE2" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/"><em>ACE2</em></sd-tag> <sd-tag id="sdTag32" source="sdapi" category="assay" entity_type="None" role="None" text="expression" ext_ids="BAO_0002785" ext_dbs="" in_caption="True" ext_names="gene expression assay" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">expression</sd-tag> changes in treated vs control samples was performed with the level 3 CMAP data of 24 hours response values using limma (Ritchie et al, 2015; Methods). (C) 672 clinically approved drugs that are each tested on four <sd-tag id="sdTag33" source="sdapi" category="disease" entity_type="None" role="None" text="carcinoma" ext_ids="DOID:305" ext_dbs="" in_caption="True" ext_names="carcinoma" ext_tax_ids="" ext_tax_names="" ext_urls=" https://identifiers.org/">carcinoma</sd-tag> cell lines from CMAP (Subramanian et al, 2017). <graphic href="https://api.sourcedata.io/file.php?panel_id=89573"/></sd-panel><sd-panel panel_id="89574">Differential <sd-tag id="sdTag37" source="sdapi" category="assay" entity_type="None" role="None" text="expression" ext_ids="BAO_0002785" ext_dbs="" in_caption="True" ext_names="gene expression assay" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">expression</sd-tag> analysis for <sd-tag id="sdTag38" source="sdapi" category="None" entity_type="gene" role="assayed" text="ACE2" ext_ids="59272" ext_dbs="" in_caption="True" ext_names="ACE2" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/"><em>ACE2</em></sd-tag> <sd-tag id="sdTag39" source="sdapi" category="assay" entity_type="None" role="None" text="expression" ext_ids="BAO_0002785" ext_dbs="" in_caption="True" ext_names="gene expression assay" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">expression</sd-tag> changes in treated vs control samples was performed with the level 3 CMAP data of 24 hours response values using limma (Ritchie et al, 2015; Methods). The <sd-tag id="sdTag40" source="sdapi" category="None" entity_type="gene" role="assayed" text="ACE2" ext_ids="59272" ext_dbs="" in_caption="True" ext_names="ACE2" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/"><em>ACE2</em></sd-tag> <sd-tag id="sdTag41" source="sdapi" category="assay" entity_type="None" role="None" text="expression" ext_ids="BAO_0002785" ext_dbs="" in_caption="True" ext_names="gene expression assay" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">expression</sd-tag> levels in control and drug-treated groups for the top significant drugs (<sd-tag id="sdTag42" source="sdapi" category="None" entity_type="molecule" role="intervention" text="vorinostat" ext_ids="CHEBI:45716" ext_dbs="" in_caption="True" ext_names="vorinostat" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=">vorinostat</sd-tag>, <sd-tag id="sdTag43" source="sdapi" category="None" entity_type="molecule" role="intervention" text="panobinostat" ext_ids="CHEBI:85990" ext_dbs="" in_caption="True" ext_names="panobinostat" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=">panobinostat</sd-tag>, and <sd-tag id="sdTag44" source="sdapi" category="None" entity_type="molecule" role="intervention" text="isotretinoin" ext_ids="CHEBI:6067" ext_dbs="" in_caption="True" ext_names="isotretinoin" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=">isotretinoin</sd-tag>) among the 672 clinically approved drugs are shown with boxplots in <strong>(D)</strong>, the <sd-tag id="sdTag45" source="sdapi" category="None" entity_type="gene" role="assayed" text="ACE2" ext_ids="59272" ext_dbs="" in_caption="True" ext_names="ACE2" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/"><em>ACE2</em></sd-tag> <sd-tag id="sdTag46" source="sdapi" category="assay" entity_type="None" role="None" text="expression" ext_ids="BAO_0002785" ext_dbs="" in_caption="True" ext_names="gene expression assay" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">expression</sd-tag> log fold-change values and adjusted P values from limma, as well as the number of samples per group are labeled for each drug. In the boxplot of panel (D), the center line, box edges and whiskers denotes the median, interquartile range and the rest of the distribution in respective order, except for points that were determined to be outliers using a method that is a function of the interquartile range, as in standard box plots. <graphic href="https://api.sourcedata.io/file.php?panel_id=89574"/></sd-panel><sd-panel panel_id="89575">Differential <sd-tag id="sdTag47" source="sdapi" category="assay" entity_type="None" role="None" text="expression" ext_ids="BAO_0002785" ext_dbs="" in_caption="True" ext_names="gene expression assay" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">expression</sd-tag> analysis for <sd-tag id="sdTag48" source="sdapi" category="None" entity_type="gene" role="assayed" text="ACE2" ext_ids="59272" ext_dbs="" in_caption="True" ext_names="ACE2" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/"><em>ACE2</em></sd-tag> <sd-tag id="sdTag49" source="sdapi" category="assay" entity_type="None" role="None" text="expression" ext_ids="BAO_0002785" ext_dbs="" in_caption="True" ext_names="gene expression assay" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">expression</sd-tag> changes in treated vs control samples was performed with the level 3 CMAP data of 24 hours response values using limma (Ritchie et al, 2015; Methods). The enrichment of positive/negative <sd-tag id="sdTag50" source="sdapi" category="None" entity_type="gene" role="assayed" text="ACE2" ext_ids="59272" ext_dbs="" in_caption="True" ext_names="ACE2" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/"><em>ACE2</em></sd-tag> <sd-tag id="sdTag51" source="sdapi" category="assay" entity_type="None" role="None" text="expression" ext_ids="BAO_0002785" ext_dbs="" in_caption="True" ext_names="gene expression assay" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">expression</sd-tag> regulators in different drug classes based on their mechanism of action (MOA) was tested with the <sd-tag id="sdTag52" source="sdapi" category="assay" entity_type="None" role="None" text="GSEA" ext_ids="BAO_0002356" ext_dbs="" in_caption="True" ext_names="GSEA-P enrichment analysis" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">GSEA</sd-tag> method as implemented in the R package fgsea (Segushichev, 2016; Methods), and the enrichment significance (negative log10 P values) is shown in bar plots in (E), for the analysis on the 672 clinically approved drugs We further extended the analysis to a larger set of 989 clinically approved drugs tested on a total of 28 cell lines (16 <sd-tag id="sdTag53" source="sdapi" category="disease" entity_type="None" role="None" text="cancer" ext_ids="DOID:162" ext_dbs="" in_caption="True" ext_names="cancer" ext_tax_ids="" ext_tax_names="" ext_urls=" https://identifiers.org/">cancer</sd-tag> and 12 normal cells; this list is provided in Table EV2A with details including primary site, subtype and donor demographics) where each drug may have been tested on a different subset of cells (Methods). and performed enrichment analysis using the WHO ATC drug classification data (World Health Organization, 2006), and top enriched drug classes are shown in <strong>(F)</strong>. <graphic href="https://api.sourcedata.io/file.php?panel_id=89575"/></sd-panel></fig><fig id="34262"><title>: Drug-induced ACE2 differential expression in lung and kidney-derived cells or tissue types from the GEO database.</title><label>Figure 2</label><graphic href="https://api.sourcedata.io/file.php?figure_id=34262"/><sd-panel panel_id="89576">(A-D) This Fig summarizes the differential <sd-tag id="sdTag76" source="sdapi" category="assay" entity_type="None" role="None" text="expression" ext_ids="BAO_0002785" ext_dbs="" in_caption="True" ext_names="gene expression assay" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">expression</sd-tag> analysis results for <sd-tag id="sdTag77" source="sdapi" category="None" entity_type="gene" role="assayed" text="ACE2" ext_ids="59272" ext_dbs="" in_caption="True" ext_names="ACE2" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/"><em>ACE2</em></sd-tag> upon treatment by clinically approved drugs in samples of <sd-tag id="sdTag78" source="sdapi" category="None" entity_type="tissue" role="experiment" text="lung" ext_ids="UBERON:0002048" ext_dbs="" in_caption="True" ext_names="lung" ext_tax_ids="" ext_tax_names="" ext_urls="https://www.ebi.ac.uk/ols/ontologies/uberon/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FUBERON_">lung</sd-tag> and <sd-tag id="sdTag79" source="sdapi" category="None" entity_type="tissue" role="experiment" text="kidney" ext_ids="UBERON:0002113" ext_dbs="" in_caption="True" ext_names="kidney" ext_tax_ids="" ext_tax_names="" ext_urls="https://www.ebi.ac.uk/ols/ontologies/uberon/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FUBERON_">kidney</sd-tag> datasets mined from the GEO database, spanning both <sd-tag id="sdTag80" source="sdapi" category="disease" entity_type="None" role="None" text="cancer" ext_ids="DOID:162" ext_dbs="" in_caption="True" ext_names="cancer" ext_tax_ids="" ext_tax_names="" ext_urls=" https://identifiers.org/">cancer</sd-tag> and non-<sd-tag id="sdTag81" source="sdapi" category="disease" entity_type="None" role="None" text="cancer" ext_ids="DOID:162" ext_dbs="" in_caption="True" ext_names="cancer" ext_tax_ids="" ext_tax_names="" ext_urls=" https://identifiers.org/">cancer</sd-tag> datasets (Methods). Volcano plots showing the log fold-change (X-axis) and uncorrected negative log<sub>10</sub>P value (Y-axis) of <sd-tag id="sdTag82" source="sdapi" category="None" entity_type="gene" role="assayed" text="ACE2" ext_ids="70008" ext_dbs="" in_caption="True" ext_names="Ace2" ext_tax_ids="10090" ext_tax_names="Mus musculus" ext_urls="http://www.ncbi.nlm.nih.gov/gene/"><em>ACE2</em></sd-tag> <sd-tag id="sdTag83" source="sdapi" category="assay" entity_type="None" role="None" text="expression" ext_ids="BAO_0002785" ext_dbs="" in_caption="True" ext_names="gene expression assay" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">expression</sd-tag> changes are displayed in <strong>(A)</strong> for 74 datasets of cells or tissue samples from <sd-tag id="sdTag84" source="sdapi" category="None" entity_type="tissue" role="experiment" text="lung" ext_ids="UBERON:0002048" ext_dbs="" in_caption="True" ext_names="lung" ext_tax_ids="" ext_tax_names="" ext_urls="https://www.ebi.ac.uk/ols/ontologies/uberon/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FUBERON_">lung</sd-tag>, involving 42 clinically approved drugs, and in <strong>(C)</strong> for 35 <sd-tag id="sdTag85" source="sdapi" category="None" entity_type="tissue" role="experiment" text="kidney" ext_ids="UBERON:0002113" ext_dbs="" in_caption="True" ext_names="kidney" ext_tax_ids="" ext_tax_names="" ext_urls="https://www.ebi.ac.uk/ols/ontologies/uberon/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FUBERON_">kidney</sd-tag> datasets involving 29 clinically approved drugs. Among these, we focused on the top significant drugs that modulate <sd-tag id="sdTag86" source="sdapi" category="None" entity_type="gene" role="assayed" text="ACE2" ext_ids="59272" ext_dbs="" in_caption="True" ext_names="ACE2" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/"><em>ACE2</em></sd-tag> <sd-tag id="sdTag87" source="sdapi" category="assay" entity_type="None" role="None" text="expression" ext_ids="BAO_0002785" ext_dbs="" in_caption="True" ext_names="gene expression assay" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">expression</sd-tag> in non-cancerous cells or tissue samples from <sd-tag id="sdTag88" source="sdapi" category="None" entity_type="tissue" role="experiment" text="lung" ext_ids="UBERON:0002048" ext_dbs="" in_caption="True" ext_names="lung" ext_tax_ids="" ext_tax_names="" ext_urls="https://www.ebi.ac.uk/ols/ontologies/uberon/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FUBERON_">lung</sd-tag> and <sd-tag id="sdTag89" source="sdapi" category="None" entity_type="tissue" role="experiment" text="kidney" ext_ids="UBERON:0002113" ext_dbs="" in_caption="True" ext_names="kidney" ext_tax_ids="" ext_tax_names="" ext_urls="https://www.ebi.ac.uk/ols/ontologies/uberon/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FUBERON_">kidney</sd-tag>, which are shown in <strong>(B)</strong> and <strong>(D)</strong>, respectively, where the <sd-tag id="sdTag90" source="sdapi" category="None" entity_type="gene" role="assayed" text="ACE2" ext_ids="302668" ext_dbs="" in_caption="True" ext_names="Ace2" ext_tax_ids="10116" ext_tax_names="Rattus norvegicus" ext_urls="http://www.ncbi.nlm.nih.gov/gene/"><em>ACE2</em></sd-tag> <sd-tag id="sdTag91" source="sdapi" category="assay" entity_type="None" role="None" text="expression" ext_ids="BAO_0002785" ext_dbs="" in_caption="True" ext_names="gene expression assay" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">expression</sd-tag> (Y-axis) difference between control and treated groups (X-axis) are shown with boxplots. In the title of each boxplot, the GEO identifier of the respective studies and the corresponding drug name and the sample type are provided. Different datasets involving experiments using the same drug were analyzed and presented separately, since the sample types can be different across datasets. All the P values are computed from differential <sd-tag id="sdTag92" source="sdapi" category="assay" entity_type="None" role="None" text="expression" ext_ids="BAO_0002785" ext_dbs="" in_caption="True" ext_names="gene expression assay" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">expression</sd-tag> analysis using limma (Ritchie et al, 2015) (Methods). In the boxplots of panels (B) and (D), the center line, box edges and whiskers denotes the median, interquartile range and the rest of the distribution in respective order, except for points that were determined to be outliers using a method that is a function of the interquartile range, as in standard box plots. Abbreviations: <sd-tag id="sdTag93" source="sdapi" category="None" entity_type="cell" role="experiment" text="HBEC" ext_ids="CL:0002328" ext_dbs="" in_caption="True" ext_names="bronchial epithelial cell" ext_tax_ids="" ext_tax_names="" ext_urls=" https://identifiers.org/">HBEC</sd-tag>, <sd-tag id="sdTag94" source="sdapi" category="None" entity_type="organism" role="component" text="human" ext_ids="9606" ext_dbs="" in_caption="True" ext_names="Homo sapiens" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ncbi.nlm.nih.gov/taxonomy/">human</sd-tag> primary <sd-tag id="sdTag95" source="sdapi" category="None" entity_type="cell" role="experiment" text="bronchial epithelial cells" ext_ids="CL:0002328" ext_dbs="" in_caption="True" ext_names="bronchial epithelial cell" ext_tax_ids="" ext_tax_names="" ext_urls=" https://identifiers.org/">bronchial epithelial cells</sd-tag>. <graphic href="https://api.sourcedata.io/file.php?panel_id=89576"/></sd-panel></fig></article>